James H Jr Greene Net Worth

The estimated Net Worth of James H Jr Greene is at least $809 millió dollars as of 19 August 2005. James Greene owns over 37,917 units of Global X Funds stock worth over $1,054,253 and over the last 22 years James sold AIQ stock worth over $807,936,004.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

James Greene AIQ stock SEC Form 4 insiders trading

James has made over 4 trades of the Global X Funds stock since 2004, according to the Form 4 filled with the SEC. Most recently James exercised 37,917 units of AIQ stock worth $97,447 on 19 August 2005.

The largest trade James's ever made was selling 31,500,000 units of Global X Funds stock on 2 December 2004 worth over $723,870,000. On average, James trades about 950,051 units every 7 days since 2003. As of 19 August 2005 James still owns at least 30,417 units of Global X Funds stock.

You can see the complete history of James Greene stock trades at the bottom of the page.

What's James Greene's mailing address?

James's mailing address filed with the SEC is C/O KKR, 9 W 57TH ST, NEW YORK, NY, 10019.

Insiders trading at Global X Funds

Over the last 21 years, insiders at Global X Funds have traded over $406,216,779 worth of Global X Funds stock and bought 11,973,300 units worth $47,156,496 . The most active insiders traders include Henry R Kravis, James H Jr Greene és Alexandar Jrraether Paul Er.... On average, Global X Funds executives and independent directors trade stock every 92 days with the average trade being worth of $57,648,557. The most recent stock trade was executed by Rhonda A Longmore Grund on 19 May 2016, trading 2,500 units of AIQ stock currently worth $18,975.

What does Global X Funds do?

Complete history of James Greene stock trades at Amphenol, O-I Glass Inc és Global X Funds

Global X Funds executives and stock owners

Global X Funds executives and other stock owners filed with the SEC include:

• R Brian Hanson,
  Executive VP & CFO
• Russell D Jr Phillips,
  EVP, Gen.Coun.,Secre.
• Henry R Kravis,
  Director
• Kenneth S Ord,
  Executive VP & CFO
• Rhonda A Longmore Grund,
  EVP and CFO
• Heping Feng,
  
• Tao L. Zhang,
  
• Edward L Samek,
  Director
• Richard A. Jones,
  Executive Vice President
• Neil F Dimick,
  Director
• Paul S Viviano,
  Chairman, President & CEO
• Richard W Johns,
  EVP, General Counsel & Sec.
• Percy C Jr Tomlinson,
  President & CEO
• Gregory E. Spurlock,
  President. Alliance Oncology
• Christianna S Rosow,
  Principal Accounting Officer
• Scott A Bartos,
  Director
• Larry C. Buckelew,
  Director
• Howard K Aihara,
  VP & Corporate Controller
• Deborah Rodriguez,
  EVP, Human Resources
• Michael J Shea,
  Chief Operating Officer
• Nicholas A Poan,
  VP, Corporate Controller
• Eli H Glovinsky,
  Exec.VP,Gen.Coun,Corp.Secre.
• Michael F Frisch,
  Executive Vice President & COO
• Richard J Hall,
  President, Alliance Oncology
• Curtis Lane,
  Director
• Christopher J Joyce,
  Executive Vice President, M&A
• Aaron Bendikson,
  Director
• Health Investors Ii, Lp All...,
  
• Anthony B Helfet,
  Director
• Principal Opportunities Fun...,
  
• Michael P Harmon,
  Director
• Health Investors Ii, Lp All...,
  
• Alexandar Jrraether Paul Er...,
  
• James C Momtazee,
  Director
• Michael W Michelson,
  Director
• Kenneth W/Nj Freeman,
  Director
• 1996 Gp Llckkr Associates 1...,
  
• James H Jr Greene,
  Director
• Adam Clammer,
  Director
• Andrew P Hayek,
  Executive VP & COO